通过分析皮层下核的合成MRI定量参数来解释帕金森病的不同运动亚型的分类
Dongliang Cheng1, Junyan Wen2, Yulin Liu3
1Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Radiology, The First People's Hospital of Foshan, Foshan, China.
European journal of radiology
|July 4, 2025
概括
合成MRI揭示了帕金森病运动亚型中明显的大脑变化. 这种方法有效地区分了震主导和姿势不稳定和走路困难亚型,有助于诊断.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 呈现出多种运动亚型,包括震主导 (TD) 和姿势不稳定和步行困难 (PIGD).
- 皮质下核的改变与PD病理生理学有关,但亚型特定的定量差异仍未得到充分研究.
- 合成MRI (SyMRI) 提供了对大脑组织属性的先进定量成像.
研究的目的:
- 调查PD运动亚型 (TD和PIGD) 和健康对照 (HCs) 之间的皮层下核的定量SyMRI参数差异.
- 开发一种可解释的机器学习模型,使用这些定量参数来区分PD亚型.
主要方法:
- 102名PD患者 (43名TD,59名PIGD) 和42名HC患者接受了SyMRI,从16个皮层下核中提取T1,T2,质子密度 (PrD) 和髓含量 (MYC).
- 最小绝对收缩和选择操作员 (LASSO) 回归确定了支持向量机 (SVM) 分类的特征.
- 沙普利分析 (SHAP) 用于模型解释性.
主要成果:
- 与TD亚型相比,PIGD亚型在基底细胞核中显示出更明显的SyMRI参数变化,特别是T1和T2值.
- 分类模型实现了高AUC值:PIGD与HC (0.897培训,0.818验证),TD与HC (0.847培训,0.787验证),以及PIGD与TD (0.820培训,0.769验证).
- SHAP分析发现了关键的差异化特征,包括T2_R_putamen,MYC_L_GPi,MYC_R_SN,T1_R_SN,T1_L_STN,PrD_R_GPe和MYC_R_GPe.
结论:
- 在帕金森病中,SyMRI有效检测大脑微观结构损伤.
- 定量SyMRI参数可以可靠地区分PD电机亚型.
- SHAP分析为预测PD亚型分类的特定神经成像特征提供了关键的见解.
更多相关视频
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
3.7K
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
12.2K
相关概念视频
Neural Regulation
40.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.3K
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
